Latest News

Latest News

News from the World Hepatitis Alliance

Promoting screening among high risk communities with new multi-lingual tool

31 Jan 2015 Bridie Taylor

In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...

Supporting the development of national action plans in South America

31 Jan 2015 Bridie Taylor

Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...

Exploring new treatment developments and innovative ways to finance healthcare

31 Jan 2015 Bridie Taylor

New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...


News from infohep

Tenofovir DF does not reduce the risk of mother-to-child hepatitis B transmission

14 Mar 2018 Liz Highleyman
Mothers who took tenofovir disiproxil fumarate (Viread) during pregnancy did not have a significantly lower risk of transmitting hepatitis B virus (...

Elimination of hepatitis C in Europe requires greater focus on prisoners and people who inject drugs

26 Feb 2018 Keith Alcorn
Efforts to eliminate viral hepatitis in Europe will need to focus on people who inject drugs and prisoners if European Union nations are to achieve...

Smoking threatens health gains from hepatitis C treatment, US researchers warn

22 Feb 2018 Keith Alcorn
People with hepatitis C in the United States are at least three times more likely to smoke than the general population but little is being done to...

Severe fibrosis improves in most people after hepatitis C cure but persists in a quarter

18 Feb 2018 Michael Carter
Hepatitis C virus (HCV)-related liver fibrosis improves significantly in the majority of people with pre-treatment advanced fibrosis or cirrhosis...

Harm reduction scale-up needed to eliminate HCV in people who inject drugs, European model predicts

1 Feb 2018 Keith Alcorn
Elimination of hepatitis C among people who inject drugs in Europe will require simultaneous scale-up of direct-acting antiviral treatment, needle...

NHS England seeks drug price cuts to eliminate hepatitis C by 2025

30 Jan 2018 Keith Alcorn
NHS England announced this week that it aims to eliminate hepatitis C by 2025 – if it can negotiate 'best value for money' deals with the...

Secondary liver cancer after colorectal cancer more common in people with chronic hepatitis B

22 Jan 2018 Keith Alcorn
The spread of cancer from the bowel to the liver – metastasis – is more likely to occur in people with chronic hepatitis B infection, a Chinese study...

Smoking reduces survival after liver cancer diagnosis for people with viral hepatitis

18 Jan 2018 Keith Alcorn
People with viral hepatitis who smoked were three times more likely to die after being diagnosed with liver cancer (hepatocellular carcinoma, HCC...

Hepatitis C treatment highly effective in harder-to-treat people with HIV co-infection, Spanish real-life study shows

16 Jan 2018 Michael Carter
Hepatitis C virus (HCV) treatment using direct-acting antivirals (DAAs) is highly effective and safe in harder-to-treat people with HIV co-...

Treatment that interferes with viral assembly shows promise for hepatitis B

18 Dec 2017 Liz Highleyman
JNJ-56136379, an experimental drug that interferes with assembly of the hepatitis B virus (HBV) capsid, demonstrated potent antiviral activity in an...